16 employees
Athos develops AI-based Precision Therapeutics for patients with Inflammatory Bowel, other Autoimmune Diseases, and cancer.
$26M sweet spot round size
Most of their 1 investments are in rounds between $26M and $26M
2019
RedDress Ltd. raised $26M on May 24, 2023
Investors: HCS Capital, Ragnar Crossover Fund and Athos Therapeutics Inc